Merck & Co., Inc.
Merck & Co., Inc. 6MK.DE Peers
See (6MK.DE) competitors and their performances in Stock Market.
Peer Comparison Table: Drug Manufacturers - General Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
---|---|---|---|---|---|---|
6MK.DE | €70.00 | -1.27% | 175.8B | 11.67 | €6.00 | +3.78% |
LLY.DE | €709.30 | +1.81% | 672.2B | 66.17 | €10.72 | +0.64% |
JNJ.DE | €135.70 | -0.98% | 326.5B | 17.29 | €7.85 | +3.02% |
4AB.DE | €166.80 | +0.24% | 294.6B | 81.37 | €2.05 | +3.15% |
ZEG.DE | €128.75 | -0.35% | 199.6B | 29.67 | €4.34 | +2.12% |
AMG.DE | €255.60 | -1.06% | 137.4B | 26.71 | €9.57 | +3.32% |
PFE.DE | €21.37 | +0.23% | 121.5B | 17.66 | €1.21 | +6.58% |
PFE.F | €21.26 | -0.28% | 120.8B | 17.57 | €1.21 | +6.59% |
GIS.DE | €96.13 | -0.82% | 119.6B | 23.00 | €4.18 | +2.74% |
SNW.DE | €86.57 | -1.13% | 105.5B | 17.35 | €4.99 | +4.52% |
Stock Comparison
6MK.DE vs LLY.DE Comparison
6MK.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6MK.DE stands at 175.8B. In comparison, LLY.DE has a market cap of 672.2B. Regarding current trading prices, 6MK.DE is priced at €70.00, while LLY.DE trades at €709.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6MK.DE currently has a P/E ratio of 11.67, whereas LLY.DE's P/E ratio is 66.17. In terms of profitability, 6MK.DE's ROE is +0.38%, compared to LLY.DE's ROE of +0.77%. Regarding short-term risk, 6MK.DE is more volatile compared to LLY.DE. This indicates potentially higher risk in terms of short-term price fluctuations for 6MK.DE.